SCHEMBL19664183

SCHEMBL19664183

CN(C)C(On1nnc2cccc(N=N)c21)=[N+](C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28381910 0.95
SCHEMBL19462711 0.95
SCHEMBL27189112 0.84
SCHEMBL20582581 0.78 KCNMA1 (0.31)
SCHEMBL19873364 0.77
SCHEMBL29544944 0.75 SIRT2 (0.49)
SCHEMBL118552 0.75 SIRT2 (0.49)
Fluoride Ion SCHEMBL4594160 0.74 SIRT2 (0.48)
Bromide SCHEMBL5514450 0.74 SIRT2 (0.48)
SCHEMBL30056078 0.74 SIRT2 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3067351-B1 COMPOUND HAVING HIGHER INHIBITION OF PROTEIN KINASE G ACTIVITY AND PREPARATION METHOD THEREFOR JENKEM TECH CO LTD TIANJIN (CN) 2019-02-06 EP claimed
US-20240092774-A1 HETEROAROMATIC COMPOUNDS AND USES THEREOF HUTCHISON MEDIPHARMA LIMITED (CN) 2024-03-21 US disclosed
US-20190010204-A1 METHOD FOR PREPARING SERMAGLUTIDE Hybio Pharmaceutical Co., Ltd. (CN) 2019-01-10 US disclosed
EP-3251698-A1 LIGAND-CYTOTOXICITY DRUG CONJUGATE, PREPARING METHOD THEREFOR, AND APPLICATION THEREOF Jiangsu Hengrui Medicine Co. Ltd. (CN) 2017-12-06 EP disclosed